Search

Search Constraints

You searched for: Author/Creator Metra, Marco

Search Results

1. 'Time is prognosis' in heart failure: time‐to‐treatment initiation as a modifiable risk factor. (16th October 2021)

3. 128 Clinical impact of changes in mitral regurgitation severity after optimization of medical therapy in heart failure: insights from BIOSTAT-CHF. (8th December 2021)

4. 132 PREVALENCE CHARACTERISTICS AND OUTCOMES OF COVID 19 ASSOCIATED ACUTE MYOCARDITIS. (15th December 2022)

5. 132 Clinical characteristics and outcomes of a contemporary, real-world, single-centre cohort of patients with advanced heart failure. (8th December 2021)

6. 138 OUTCOME AND MORPHO-FUNCTIONAL CHANGES ON CARDIAC MAGNETIC RESONANCE IN PATIENT WITH ACUTE MYOCARDITIS FOLLOWING MRNA COVID 19 VACCINATION. (15th December 2022)

7. 152 PERFORMANCE OF RISK STRATIFICATION SCORES AND ROLE OF COMORBIDITIES IN OLDER VS YOUNGER PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION. (15th December 2022)

8. 190 SARS-CoV-2 associated myopericarditis in a patient with previous myocarditis. (8th December 2021)

9. 192 Study of endothelial function and vascular stiffness in patients affected by dilated cardiomyopathy on treatment with sacubitril/valsartan. (8th December 2021)

10. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. (27th January 2022)